Gainesville, FL, United States of America

Anuj Chauhan

This inventor holds 29 USPTO granted patents and 16 published patent applications and 1 EPO patent, primarily in Ophthalmic Drug Delivery. Top assignees: University of Florida Research Foundation Inc., Tearclear Corp., Trustees of the Colorado School of Mines. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anuj Chauhan. Retrieved from https://idiyas.com/inventor/anuj-chauhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 29 

% Patents Active = 86.2

 

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 172(Granted Patents)


Location History:

  • Gainesville, FL (US) (2009 - 2024)
  • Golden, CO (US) (2020 - 2024)

Company Filing History:


Years Active: 2009-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Ophthalmological Medications
Intravitreal Injection
Preservative Removal
Retinal Drug Delivery
Cannabidiol Formulations
Hydrophilic Drugs
Contact Lenses
Bioactive Agents
Stable Emulsions
Iontophoretic Delivery
Cystine Crystals
Hydrogels
29 patents (USPTO):Explore Patents

Title: Anuj Chauhan: Innovator in Retinal Drug Delivery and Cystinosis Treatment

Introduction

Anuj Chauhan, based in Gainesville, Florida, is a prominent inventor with a remarkable portfolio of 25 patents. His work primarily focuses on innovative devices and methods that enhance medical treatments, especially related to ocular health.

Latest Patents

Among his latest breakthroughs, Chauhan has filed patents for devices and methods aimed at reducing cystine crystals in vivo. This includes the development of removable intra-ocular devices and contact lenses infused with cystine-sequestering materials designed to effectively absorb cystine from the eyes of patients suffering from cystinosis. Furthermore, Chauhan has devised methods for creating these specialized contact lenses. Another significant patent pertains to methods and compositions for retinal drug delivery, which enables extended release of therapeutic agents in the retina through intravitreal injection, enhancing the efficacy of treatment for retinal disorders.

Career Highlights

Chauhan has had an influential career, contributing to significant advancements in the field of ocular therapies. He has worked with the University of Florida Research Foundation and Tearclear Corporation, where he focused on the translation of cutting-edge research into practical applications for patients.

Collaborations

Throughout his career, Anuj Chauhan has collaborated with notable professionals, including Phillip J. Dixon and Kuan-Hui Hsu, which has facilitated the sharing of knowledge and expertise essential for advancing innovations in medical technologies.

Conclusion

Anuj Chauhan's contributions to the fields of drug delivery and cystinosis treatment exemplify the impact of innovative thinking in health care. His patents not only reflect his commitment to improving patient outcomes but also underscore the importance of collaboration in driving forward advancements in medical technologies. As an inventor, Chauhan continues to play a vital role in the evolution of therapeutic strategies aimed at combatting challenging medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…